B01.2 Varicella pneumonia

Name of the Condition

• Varicella pneumonia

Summary

Varicella pneumonia is a serious complication of varicella (chickenpox) infection, characterized by inflammation of the lung tissue due to the varicella-zoster virus (VZV). It is more common in adults and immunocompromised individuals and can range from mild to severe, potentially requiring hospitalization. The condition involves viral invasion of the respiratory tract, leading to pulmonary symptoms that may overlap with other respiratory illnesses.

Causes

Varicella pneumonia is caused by the varicella-zoster virus (VZV), the same virus responsible for chickenpox. The virus spreads to the lungs during or after a primary varicella infection, either through direct viral invasion of lung tissue or an immune-mediated inflammatory response. This complication typically occurs in individuals with impaired immune systems or in adults who develop varicella.

Risk Factors

• Lack of prior varicella vaccination or previous infection.
• Immunocompromised states, such as HIV/AIDS, chemotherapy, or chronic steroid use.
• Age, with adults at higher risk for severe disease compared to children.
• Pregnancy, which increases the risk of severe maternal complications.
• Underlying lung conditions, such as chronic obstructive pulmonary disease (COPD).

Symptoms

• Persistent cough, often dry or productive.
• Shortness of breath or difficulty breathing.
• Chest pain, which may worsen with deep breaths.
• Fever and chills.
• Fatigue and general malaise.
• In severe cases, respiratory failure or hypoxemia.

Diagnosis

Diagnosis of varicella pneumonia involves a combination of clinical evaluation and diagnostic testing. A healthcare provider will assess symptoms, medical history, and exposure to varicella. Imaging studies, such as a chest X-ray or CT scan, may show characteristic patterns of lung inflammation. Laboratory tests, including PCR or viral culture of respiratory samples, can confirm the presence of VZV. Blood tests may also be used to detect viral antibodies or assess immune function.

Treatment Options

Treatment focuses on managing symptoms and supporting respiratory function. Antiviral medications, such as acyclovir, may be prescribed to reduce viral replication, especially in high-risk patients. Supportive care includes oxygen therapy for hypoxemia, hydration, and monitoring for respiratory distress. In severe cases, hospitalization and mechanical ventilation may be necessary. Corticosteroids are generally avoided unless there is a specific indication, such as severe inflammation.

Prognosis and Follow-Up

The prognosis for varicella pneumonia varies depending on the patient's overall health and the severity of the infection. Most healthy individuals recover with appropriate treatment, but immunocompromised patients or those with severe disease may have a higher risk of complications. Follow-up care includes monitoring respiratory function and ensuring resolution of symptoms. Long-term lung damage is rare but possible in severe cases.

Complications

• Respiratory failure requiring mechanical ventilation.
• Secondary bacterial pneumonia.
• Acute respiratory distress syndrome (ARDS).
• Prolonged viral shedding, increasing transmission risk.
• In rare cases, progression to multi-organ failure.

Lifestyle & Prevention

• Vaccination against varicella is the most effective prevention strategy.
• Avoid close contact with individuals who have active varicella infections.
• Practice good hand hygiene to reduce transmission risk.
• For high-risk individuals, post-exposure prophylaxis with antivirals may be considered.
• Quit smoking and manage underlying lung conditions to reduce susceptibility.

When to Seek Professional Help

Seek immediate medical attention if you experience severe respiratory symptoms, such as difficulty breathing, chest pain, or high fever, especially if you have a history of varicella or are immunocompromised. Early intervention can improve outcomes and reduce the risk of complications.

Tips for Medical Coders

When coding for varicella pneumonia (B01.2), ensure documentation supports the diagnosis, including clinical findings, imaging results, and laboratory confirmation of VZV. Differentiate from other respiratory conditions, such as bacterial pneumonia, which may require additional coding. Verify that the code aligns with the patient's clinical presentation and any associated risk factors, such as immunocompromised status, to ensure accurate reporting.